This biotech name is one of Jim Cramer's favorite stocks and he thinks it can go even higher 0 21.08.2023 17:52 CNBC "I think it's going to be worth more," Jim Cramer said Monday after Regeneron got good news from the FDA on its macular degeneration treatment. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
